RegistriesAlternative SplicingIncidenceTreatment OutcomeRisk FactorsTime FactorsUnited StatesRetrospective StudiesFollow-Up StudiesProspective StudiesDenmarkCohort StudiesNeoplasmsRisk AssessmentAge FactorsSEER ProgramSurvival RateInfant, NewbornComplement Pathway, AlternativeSurvival AnalysisEuropeAge DistributionDatabases, FactualHospital MortalityRare DiseasesNorwaySwedenAngioplasty, Balloon, CoronaryPrognosisMyocardial InfarctionLogistic ModelsProportional Hazards ModelsPopulation SurveillanceMedical Record LinkageMultivariate AnalysisBreast NeoplasmsPatient SelectionSex FactorsAnimal Testing AlternativesKaplan-Meier EstimateGermanyDrug-Eluting StentsFranceOdds RatioSex DistributionExonsHospital RecordsStrokeItalyMolecular Sequence DataDiseases in TwinsStentsChi-Square DistributionRiskData CollectionCause of DeathResearch DesignAustraliaComplementary TherapiesSpainJapanHospitalizationPrevalenceQuestionnairesMedical RecordsReproducibility of ResultsCaliforniaSeverity of Illness IndexBase SequenceCase-Control StudiesComorbidityOutcome Assessment (Health Care)PregnancyTwins, DizygoticCanadaTwins, MonozygoticCongenital AbnormalitiesSurvivorsPercutaneous Coronary InterventionPostoperative ComplicationsFinlandInternational CooperationCardiovascular AgentsDeath CertificatesConfidence IntervalsProduct Surveillance, PostmarketingNetherlandsNorth AmericaProsthesis DesignRecurrencePredictive Value of TestsClinical CodingNeoplasm StagingAcute Coronary SyndromeRegression AnalysisEpidemiologic MethodsRandomized Controlled Trials as TopicCoronary Artery DiseasePlatelet Aggregation InhibitorsTissue Donors